Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma. Issue 1 (13th April 2022) - Grogan, Patrick T; Deming, Dustin A; Helgager, Jeffrey; Ruszkiewicz, Theresa; Baskaya, Mustafa K; Howard, Steven P; Robins, H Ian